Ribosomal Display Fab Fragment Selection via Segmented Chain Assembly

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for selecting Fab fragments using ribosomal display technology face challenges in efficiently selecting multichain proteins like Fab fragments due to kinetics of chain association being too slow relative to mRNA degradation, limiting the selection of such proteins.

Innovation Solution

A method involving the generation of DNA libraries encoding variable heavy (VH) and variable light (VL) chain domains, where VH chain domains are translated in a cell-free protein synthesis system with separate addition of VL chain domains, allowing for the formation and selection of Fab fragments that bind to antigens, overcoming the limitations of prior art by maintaining genotype-phenotype linkage for only one chain in a multi-chain protein.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional ribosomal display systems are used to select multichain proteins like Fab fragments, then the selection process should theoretically work, but the kinetics of chain association are too slow relative to mRNA degradation, causing the selection to fail

Engineering Contradiction:
Improveselection efficiencyVSAvoidchain association kinetics
Core Design Contradiction:
ReliabilityVSSpeed

Solution Approach 1:

The invention segments the Fab fragment selection process into two independent libraries: a first library containing VH chain domains with associated mRNA and ribosomes, and a second library containing VL chain domains. This segmentation allows each chain to be independently optimized and combined, bypassing the kinetic limitations of traditional multichain assembly where all chains must associate simultaneously before mRNA degradation occurs.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention performs preliminary action by pre-assembling the VH chain with its mRNA and ribosome in the first library, maintaining the genotype-phenotype linkage. The VL chain is then added in a subsequent step to complete the Fab fragment assembly. This staged approach ensures that the VH-mRNA-ribosome complex is stable and ready for VL incorporation before mRNA degradation can occur, effectively preparing the system for successful multichain assembly.

Inventive Principle:
Principle #10Preliminary action

2Ease of manufacture

If multichain assembly is attempted in traditional ribosomal display systems, then complete Fab fragments can be formed, but the process becomes inefficient due to slow chain association kinetics

Engineering Contradiction:
ImproveFab fragment productionVSAvoidselection throughput
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

By dividing the Fab fragment into two separate libraries (VH-containing and VL-containing), the invention simplifies the manufacturing process for each component while enabling high-throughput selection. Each library can be independently optimized and scaled, and their combination yields complete Fab fragments without the kinetic bottlenecks of traditional simultaneous multichain assembly.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses the ribosome-mRNA complex as an intermediary carrier that stabilizes the VH chain and enables its independent handling. This intermediary allows the VH chain to be maintained in a selection-ready state with its genetic information, facilitating efficient library construction and high-throughput screening before final Fab fragment assembly with the VL chain.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the efficient selection of Fab fragments from large libraries, demonstrating high affinity and specificity to target antigens, as shown by the successful binding and characterization of selected IgGs, with sub-nM EC50 values and high purity, overcoming previous limitations in selecting multimeric proteins.

Implementation Method 1

ribosomal display is a cell-free system using the principle of coupling phenotype (protein) to genotype (encoding nucleic acid such a DNA or RNA)

Methodology Applied
Scientific EffectTranslation:

Implementation Method 2

the selecting step comprises capturing the Fab fragments to an immobilized antigen

Methodology Applied
Scientific EffectAntigen-antibody binding:

Implementation Method 3

the step of generating the second library further comprises the step of transcribing DNA encoding the member of the second library

Methodology Applied
Scientific EffectTranscription:

Implementation Method 4

the step of expressing the variable chain of the second library comprises the step of expressing nucleic acid encoding the variable chain

Methodology Applied
Scientific EffectTranslation:

Data Source

PatentEP2989239B2Selection of FAB fragments using ribosomal display technology
Publication Date: 2025.01.15 SUTRO BIOPHARMA INC
  • EP2989239B2 patent drawingFigure 1A~1C
  • EP2989239B2 patent drawingFigure 2
  • EP2989239B2 patent drawingFigure 3A~3D

AI summary

The invention relates to a method for generating and selecting Fab fragments using ribosomal display and cell-free protein synthesis. The invention also provides a ribosomal display reaction system for generating Fab fragment complexes. The compositions of a Fab fragment complex and a library thereof are also provided.